Back to Search
MAGDALENA ESCHENBERG, DOULA
DOULA
NPI: 1053170043Individual
Specialties, Licenses & Credentials
Research & Publications (4)
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
PMID 19564535·J Clin Oncol·2009
3-trial
Motesanib diphosphate in progressive differentiated thyroid cancer.
PMID 18596272·N Engl J Med·2008
3-trial
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
PMID 15328168·Clin Cancer Res·2004
3-trial
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.
PMID 12837807·J Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3662 LICHAU RD
PENNGROVE, CA 94951 - Phone
- (707) 867-9973
Quick Facts
- NPI
- 1053170043
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile